Alercell's Frederic Scheer to Deliver Keynote at Montana Innovation Partnership's "Innovate Here" Conference

BOZEMAN, Mont. - EntSun -- Frederic Scheer, CEO and Chief Scientific Officer of Alercell, Inc., will serve as a keynote speaker at the upcoming Innovate Here Virtual Conference, hosted by the Montana Innovation Partnership (MTIP). The event will gather entrepreneurs, researchers, investors, and industry leaders to spotlight breakthrough technologies being built in Montana and beyond.

As keynote, Dr. Scheer will discuss how Alercell is transforming cancer diagnostics with its proprietary Deep Leukemic Cloud Platform (DLCP), a platform recently validated on more than 150,000 de-identified electronic medical records (EMRs) across multiple institutions. This large-scale, real-world validation demonstrated the DLCP's ability to detect leukemic transformation and stratify patient risk reliably and reproducibly across diverse patient populations.

"The Innovate Here conference is about building the future from Montana outward," said Scheer. "At Alercell, we've shown that AI-driven molecular diagnostics can be validated at scale, and now we are moving from discovery to commercial readiness. Our mission is to make leukemia detection early, accurate, and accessible."

More on EntSun News

• Epic Pictures' DREAD Label Sets Release Date for True-Crime Horror Film Dorothea
• Holiday Fineries at the Wineries on the Shawangunk Wine Trail
• Chadwick Twillman Demands Resignation of MLive Editor Joey Oliver for Publishing Deceptive Hit Piece
• Premiere of New Film The Ritual House October 24,
• Smile More Implant Centre Launches Cutting-Edge Website

"Alercell's breakthrough work in AI-driven cancer diagnostics embodies everything Innovate Here stands for cutting-edge research, real-world validation, and the transition from discovery to market impact. Dr. Scheer's insight into scaling biotech innovation from Montana will be invaluable for our attendees. We're honored to have a leader who's proven that transformative healthcare solutions can emerge from right here in Big Sky Country," said Ann Peterson, Program Director of the Montana Innovation Partnership.

Event Highlights:

• Keynote insights from Dr. Frederic Scheer on AI, oncology, and the path to precision diagnostics.
• Breakout sessions on innovation, commercialization, and partnerships.
• Networking opportunities across tech, life sciences, and investment sectors.

The validation of Alercell's DLCP marks a significant milestone, underscoring Montana's growing role in global biotech innovation.

About Alercell, Inc.
Alercell, Inc. is a biotech company based in Bozeman, Montana, focused on developing next-generation diagnostics for oncology. Its flagship technology, the Deep Leukemic Cloud Platform (DLCP), leverages AI and real-world patient data to deliver scalable solutions for early leukemia detection and monitoring. Alercell has filed a group of patents to protect these innovations as it advances toward commercialization.  www.alercell.com

More on EntSun News

• K2 Integrity Names Aaron Karczmer Chief Executive Officer
• Georgia's Lanier Islands Resort Announces Return of Magical Nights of Lights
• Boston Industrial Solutions' Natron® XG Series Ink Exceeds Global Safety Compliance
• West Virginia Grassroots Group Sparks Statewide Momentum in the Fight for Election Integrity
• Chaos and Clarity: OddsTrader's Latest College Football Playoff Predictions After Week 6

About the Montana Innovation Partnership and Innovate Here

The Montana Innovation Partnership (MTIP), based at Montana State University's TechLink Center, provides support and resources for technology-driven entrepreneurship. Innovate Here is MTIP's annual conference designed to connect innovators with funding, expertise, and community.

For more information, visit: montanainnovationpartnership.org/innovatehere.